Document:

EXHIBIT 10.1

 Exhibit 10.1 
 AMENDMENT NO. 2 TO EMPLOYMENT AGREEMENT 
 The Employment Agreement, dated April 30,
2009 and effective as of January 26, 2009 (the “Employment Agreement”), as amended by Amendment No. 1, dated June 16, 2010, by and between Coventry Health Care, Inc., a Delaware corporation, and Allen F. Wise, is hereby
further amended by this Amendment No. 2, entered into as of January 31, 2012 with an effective date of January 1, 2012 (together with the Employment Agreement and Amendment No. 1, the “Agreement”). Capitalized terms not
defined herein have the meanings set forth in the Employment Agreement. 
 WHEREAS, the Executive and the Company wish to extend the
Initial Term of the Agreement for an additional two years, through December 31, 2013, consistent with the Company’s desire to retain the services of the Executive; and 
 WHEREAS, the Executive and the Company wish to establish certain terms regarding the Base Salary and performance based compensation which the Executive can earn during this additional two year
period of employment; 
 NOW, THEREFORE, the Company and the Executive hereby amend the Agreement as follows by entering into this
Amendment No. 2: 
  

	1.	Amendments to the Agreement 

  

	 	(A)	Section 1.1 of the Agreement is hereby amended and restated as follows: 

“The term of the Executive’s employment commenced on January 26, 2009 and shall terminate on December 31, 2013 (the
“Initial Term”) unless the Executive’s employment is terminated sooner as outlined in Section 4 herein.” 
  

	 	(B)	The following sentence is hereby added to the end of Section 2.1 of the Agreement: 

“As of January 1, 2012, the Company shall pay the Executive a Base Salary of not less than Nine Hundred Thousand Dollars
($900,000) per annum, subject to the applicable withholdings.” 
  

	 	(C)	The last sentence of Section 2.2 of the Agreement is hereby deleted and the following shall be substituted in its place: 

“The Executive shall be eligible for an annual bonus (“Bonus”) in accordance with the Company’s performance-based plan
for purposes of 

 
Section 162(m) of the Internal Revenue Code (the “Code”), which is currently administered as the Company’s Executive Management Incentive Plan. As of January 1, 2012, the
Executive’s target annual Bonus shall equal 200% of his Base Salary and shall be earned based upon achievement of the performance targets set annually by the Committee. In no event will the annual Bonus exceed 200% of the target Bonus.”

  

	 	(D)	New Sections 2.9 and 2.10 are hereby incorporated into the Agreement as follows: 

 

	 	“2.9	On January 3, 2012, in accordance with the terms of the Incentive Plan, the Company shall grant Executive long-term performance based compensation having a grant
date value of $7,600,000 as follows: 

  

	 	(a)	81,139 restricted stock units, calculated by dividing $2,508,000 (33% of grant date value of $7,600,000) by $30.91, the closing market price of a share of the
Company’s common stock on the New York Stock Exchange on January 3, 2012 (the “2012 Closing Price”). Upon achievement of the EPS target as set by the Committee for 2012, the restricted stock units shall vest in two equal annual
increments on December 31, 2012 and on December 31, 2013. The vested restricted stock units will be settled in cash and paid out in mid-February 2014. 

 

	 	(b)	164,736 performance share units, calculated by dividing $5,092,000 (67% of grant date value of $7,600,000) by the 2012 Closing Price. The performance share units shall
vest on December 31, 2013 based on the level of achievement of the following two equally weighted performance factors: (1) the cumulative EPS earned over 2012 and 2013 relative to achievement of the aggregate 2012 and 2013 EPS targets set
by the Committee, and (2) the cumulative revenue growth during 2012 and 2013 relative to achievement of the revenue target set by the Committee. The vested performance share units will be settled in cash and paid out in mid-February 2014.”

  
 2 

	 	“2.10	On January 1, 2013, in accordance with the terms of the Incentive Plan, the Company shall grant Executive long-term performance based compensation having a grant
date value of $7,600,000 as follows: 

  

	 	(a)	that number of restricted stock units calculated by dividing $2,508,000 (33% of the grant date value of $7,600,000) by the closing market price of a share of the
Company’s stock on the New York Stock Exchange on January 2, 2013 (the “2013 Closing Price”). Upon achievement of the EPS target set by the Committee for 2013, the vested restricted stock units will be settled in cash as of
December 31, 2013 and paid out in mid-February 2014. 

  

	 	(b)	that number of performance share units calculated by dividing $5,092,000 (67% of the grant date value of $7,600,000) by the 2013 Closing Price. The performance share
units shall vest on December 31, 2013 based on the level of achievement of the following two equally weighted performance factors: (1) the cumulative EPS earned over 2012 and 2013 relative to the aggregate of the 2012 and 2013 EPS targets
set by the Committee, and (2) the cumulative revenue growth during 2012 and 2013 relative to achievement of the revenue target set by the Committee. The vested performance share units will be settled in cash and paid out in mid-February
2014.” 

  

	 	(E)	A new section 2.11 is hereby incorporated into the Agreement as follows: 

 

	 	“2.11	Notwithstanding anything herein to the contrary, with respect to the performance awards granted to Executive pursuant to this Amendment No.2 that are to be settled
in cash, such awards remain subject to any restrictions set forth in the Company’s Incentive Plan, including any limitations on the maximum annual amount of cash settled performance awards that can be earned in any performance period.”

  

	 	(F)	Section 3.1(e) is amended and restated as follows: 

  

	 	“(e)	upon the Executive’s death, all unvested outstanding awards shall vest in full. The value of the awards will be the closing market price of a share of the
Company’s stock on the New York Stock Exchange on the date of the Executive’s death and shall be settled in cash and paid to the Executive’s beneficiaries within forty-five (45) days of the Executive’s death.”

  
 3 

	 	(G)	Section 3.2(d) is amended and restated as follows: 

  

	 	“(d)	upon the Executive’s disability, all unvested outstanding awards shall vest in full. The value of the awards shall be the closing market price of a share of the
Company’s stock on the New York Stock Exchange on the date of the Executive’s disability and shall be settled in cash and paid to Executive within forty-five (45) days of the date of his disability.” 

 

	 	(H)	The second sentence of Section 4.1 is amended and restated as follows: 

“However, except in the case of a Change in Control (hereinafter defined) and if during the Initial Term of this Agreement, the
Executive suffers a Termination Without Cause (hereinafter defined) or a Constructive Termination (hereinafter defined), the Company will pay the Executive the following:” 

 

	 	(I)	Section 4.1(d) is amended and restated as follows: 

  

	 	“(d)	if the Executive’s Termination Without Cause or Constructive Termination occurs prior to January 1, 2013, the pro rata portion (based upon the number of full
months elapsed during calendar year 2012) of the restricted stock units granted to Executive pursuant to Section 2.9(a) of this Amendment No. 2 shall vest upon achievement of the 2012 EPS target set by the Committee. These vested
restricted stock units will be settled in cash and paid out in mid-February 2013. If the Executive’s Termination Without Cause or Constructive Termination occurs on or after January 1, 2013, the pro rata portion (based upon the number of
full months elapsed during the calendar year 2013) of the restricted stock units granted to Executive pursuant to Section 2.10(a) of this Amendment No. 2 shall vest upon achievement of the 2013 EPS target set by the Committee. These vested
restricted stock units will be settled in cash and paid out in mid-February 2014.” 

  

	 	(J)	Section 4.1(e) is amended and restated as follows: 

  

	 	“(e)	 if the Executive’s Termination Without Cause or Constructive Termination occurs prior to January 1, 2013, the pro rata portion (based upon
the number of full months elapsed during calendar year 2012) of the performance share units granted to Executive pursuant to Section 2.9(b) of this Amendment No. 2 shall vest upon achievement of the performance metrics set by the Committee
applicable to calendar year 2012. These vested performance share 

  
 4 

	 	
units will be settled in cash and paid out in mid-February 2013. If the Executive’s Termination Without Cause or Constructive Termination occurs on or after January 1, 2013, the pro
rata portion (based upon the number of months elapsed during the 24 month performance period) of the performance share units granted to Executive pursuant to Section 2.9(b) and Section 2.10(b) of this Amendment No. 2 shall vest upon
achievement of the performance metrics set by the Committee. These vested performance share units will be settled in cash and paid out in mid-February 2014.” 

 

	 	(K)	The first sentence of Section 4.2 is hereby amended and restated as follows: 

“if the Executive suffers a Termination Without Cause or Constructive Termination following a Change in Control, the Company will pay
to the Executive the following:” 
  

	 	(L)	Section 4.2(e) is amended and restated as follows: 

  

	 	“(e)	upon the Executive’s termination under this Section 4.2, all unvested outstanding awards shall vest in full. The awards will be immediately settled with a
cash payment based on the price per share paid in the Change in Control.” 

  

	 	(M)	The last sentence of Section 4.3 is hereby deleted and the following shall be substituted in its place: 

“Any unvested stock options, unvested restricted stock units, and unvested performance share units shall be forfeited. The vested
stock options, vested restricted stock units, vested performance share units and any other outstanding equity awards granted to the Executive shall be governed by the applicable award agreements, the Incentive Plan and, unless otherwise waived in
the Agreement, as amended, the provisions of any other incentive plans.” 
  

	2.	Continued Employment 

 Notwithstanding the Continued Employment provisions set forth in Section 5(b) of the Company’s Executive Management Incentive Plan, as such provisions may be amended from time to time,
Executive’s employment shall terminate in accordance with the Agreement, as amended, and Executive shall be eligible for payout of his vested restricted share units and vested performance share units in accordance with the terms of the
Agreement, as amended. 

  
 5 

	3.	Effect of Amendment 

Except as and to the extent expressly modified by this Amendment No. 2 and Amendment No. 1, the Agreement will remain in full
force and effect in all respects. 
  

	4.	Counterparts 

 This
Amendment No. 2 may be executed in counterparts, each of which will constitute an original and all of which, when taken together, will constitute one agreement. 
 IN WITNESS WHEREOF, the parties have executed this Amendment No. 2 as of January 31, 2012. 

 

			
	COVENTRY HEALTH CARE, INC.
		
	By:	 	 /s/ L. Dale Crandall

	Name:	 	L. Dale Crandall
	Title:	 	Chairman, Compensation Committee
	
	EXECUTIVE
		
	By:	 	 /s/ Allen F. Wise

	Name:	 	Allen F. Wise
		 	Chief Executive Officer

  
 6Letter, dated February 2, 2012, from Obsidian, LLC

 Exhibit 10.1 
 TENNENBAUM CAPITAL PARTNERS, LLC 

February 2, 2012 
 Via Facsimile and
Overnight Carrier 
 Dialogic Inc. 

1504 McCarthy Blvd., 
 Milpitas, CA 95035, United
States 
 Attention: General Counsel 

Dialogic Corporation 
 9800 Cavendish Boulevard

 5th Floor 

Montreal, Quebec, Canada H4M2V9 
 Attention:
General Counsel 
 Re: Acceleration of Loans 
 Gentlemen: 
 Reference is hereby made to that certain Second Amended and Restated
Credit Agreement by and among Dialogic Corporation, a British Columbia corporation (the “Company”), Dialogic Inc., a Delaware corporation (the “Parent” and together with the Company, collectively, the “Principal
Companies” and individually a “Principal Company”), each of the Subsidiary Guarantors signatories thereto, the lenders party thereto (the “Lenders”) and Obsidian, LLC, a Delaware limited liability company, as agent and
collateral agent for the Lenders (in such capacity, the “Agent”), dated as of October 1, 2010 (as amended, supplemented, restated or otherwise modified from time to time, the “Credit Agreement”), Capitalized terms used
herein without definition shall have the meanings set forth in the Credit Agreement. 
 The Principal Companies have informed
the Agent and the Lenders that they request a letter from the Agent and the Lenders confirming that the Lenders will not accelerate the Maturity Date of the Loans on or before March 15, 2012. 

This letter is hereby delivered to you to confirm that the Lenders will under no circumstances accelerate the Maturity Date of any Loans
prior to March 15, 2012. This letter replaces the letter dated January 5, 2012 regarding Acceleration of Loans. 
 Other than as specifically set forth above, by this letter or otherwise, the Agent and the Lenders do not waive any of their respective rights or remedies, or any existing Event of Default or any other
Events of Default or breaches or defaults of either Principal Company or any other party, or create any estoppel, in connection with the matters referred to herein or otherwise (including, without limitation, the Collateral Agent’s right to
foreclose under any of the Collateral Documents), and this letter is without prejudice to the rights and remedies of the Agent and the Lenders in respect of the Obligations and the 

2951 28TH STREET, SUITE 1000, SANTA MONICA,
CALIFORNIA 90405 
 TELEPHONE 310.566.1000
2 FACSIMILE 310.566.1010 
 2MAILBOX@TENNENBAUMCAPITAL.COM 

 Dialogic 
 2/2/2012 
 Page 2 

 

 Loan Documents, all such rights and remedies being specifically reserved and preserved. Any delay by the
Agent and the Lenders in enforcing their rights and remedies with respect to any existing or future Defaults or Events of Default does not constitute, and any future delay will not constitute, and no such delay may be construed as, (i) a waiver
of any Agent’s or any Lender’s rights and remedies or of any such Events of Default or (ii) a course of conduct on the part of any Agent or any Lender on which either Principal Company may rely at any time, and none of the foregoing
will impair the Agent’s or any Lender’s ability to exercise its rights and remedies now or in the future. Further, any single or partial exercise by the Agent or any Lender of any of its rights and remedies does not preclude any other or
further exercise by the Agent or any Lender of any available rights and remedies. 
 [REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

  
 2951
28TH STREET, SUITE 1000, SANTA MONICA, CALIFORNIA 90405 
 TELEPHONE 310.566.1000 2 FACSIMILE 310.566.1010 

2MAILBOX@TENNENBAUMCAPITAL.COM

 Dialogic 
 2/2/2012 
 Page 3 

 

			
	Very truly yours,
	
	OBSIDIAN, LLC,
	as Agent and Collateral Agent
	By: Tennenbaum Capital Partners, LLC
	Its: Sole Member
		
	By:	 	/s/  Rajneesh Vig
	Name:	 	Rajneesh Vig
	Title:	 	Authorized Signatory

  

			
	SPECIAL VALUE EXPANSION
FUND, LLC, as a Lender
	By: Tennenbaum Capital Partners, LLC
	Its: Investment Manager
		
	By:	 	/s/  Rajneesh Vig
	Name:	 	Rajneesh Vig
	Title:	 	Managing Partner

  

			
	SPECIAL VALUE OPPORTUNITIES
FUND, LLC, as a Lender
	By: Tennenbaum Capital Partners, LLC
	Its: Investment Manager
		
	By:	 	/s/  Rajneesh Vig
	Name:	 	Rajneesh Vig
	Title:	 	Managing Partner

  

			
	TENNENBAUM OPPORTUNITIES
PARTNERS V, LP, as a Lender 
	By: Tennenbaum Capital Partners, LLC
	Its: Investment Manager
		
	By:	 	/s/  Rajneesh Vig
	Name:	 	Rajneesh Vig
	Title:	 	Managing Partner

  
 2951
28TH STREET, SUITE 1000, SANTA MONICA, CALIFORNIA 90405 
 TELEPHONE 310.566.1000 2 FACSIMILE 310.566.1010 

2MAILBOX@TENNENBAUMCAPITAL.COM

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00198-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00198-of-00352.parquet"}]]